We are live on
!
Find out more
Vanguard Capital Management Portfolio holdings
AUM
$4.68T
This Fund
S&P 500
This Quarter
Est. Return
+26.64%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.68T
AUM Growth
+$637B
(+16%)
Cap. Flow
+$33.9B
Cap. Flow
% of AUM
0.72%
Top 10 Holdings %
Top 10 Hldgs %
32.56%
Holding
4,163
New
101
Increased
2,575
Reduced
1,196
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HONA
Honeywell Aerospace
HONA
|
+$4.57B |
| 2 |
SPCX
SpaceX
SPCX
|
+$4.51B |
| 3 |
Marvell Technology
MRVL
|
+$3.77B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.69B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$4.59B |
| 2 |
CTRA
Coterra Energy
CTRA
|
+$1.69B |
| 3 |
Salesforce
CRM
|
+$1.28B |
| 4 |
JPMorgan Chase
JPM
|
+$1.15B |
| 5 |
HOLX
Hologic
HOLX
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.14% |
| 2 | Financials | 12.19% |
| 3 | Industrials | 9.6% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Discretionary | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Matinas BioPharma
MTNB
$1.42M
| $24.5K | ﹤0.01% |
40,110
| – | – |
|
4002
NexGel
NXGL
$5.21M
| $24.5K | ﹤0.01% |
48,920
| – | – |
|
4003
Processa Pharmaceuticals
PCSA
$8.15M
| $24.4K | ﹤0.01% |
12,729
| – | – |
|
4004
CaliberCos
CWD
$4.58M
| $23.9K | ﹤0.01% |
36,497
+10,153
| +39% | +$9.67K |
|
4005
Tenon Medical
TNON
$2.44M
| $23.4K | ﹤0.01% |
2,049
| – | – |
|
4006
Sonoma Pharmaceuticals
SNOA
$6.22M
| $23.1K | ﹤0.01% |
18,787
| – | – |
|
4007
New Concept Energy
GBR
$3.66M
| $22.8K | ﹤0.01% |
33,021
| – | – |
|
4008
Cheetah Net Supply Chain Service
CTNT
$5.06M
| $21.7K | ﹤0.01% |
13,054
+12,981
| +17,782% | +$590K |
|
4009
Enveric Biosciences
ENVB
$6.18M
| $20.6K | ﹤0.01% |
+14,912
| New | +$35.8K |
|
|
HIND
4010
Vyome Holdings
HIND
$15.3M
| $20.3K | ﹤0.01% |
9,463
| – | – |
|
4011
Elevai Labs
ELAB
$3.97M
| $20.2K | ﹤0.01% |
+16,672
| New | +$42.2K |
|
4012
Aclarion
ACON
$7.98M
| $19.5K | ﹤0.01% |
6,782
| – | – |
|
4013
BioNTech
BNTX
$23B
| $19K | ﹤0.01% |
+204
| New | +$19.2K |
|
4014
Genprex
GNPX
$2.26M
| $18.9K | ﹤0.01% |
1,652
+1,382
| +512% | +$26.5K |
|
4015
Direct Digital Holdings
DRCT
$1.95M
| $18.7K | ﹤0.01% |
+6,905
| New | +$22K |
|
4016
Aprea Therapeutics
APRE
$8.42M
| $18.4K | ﹤0.01% |
22,882
+3,260
| +17% | +$2.72K |
|
|
PW
4017
Power REIT
PW
$2.94M
| $18.2K | ﹤0.01% |
1,891
-1
| -0.1% | -$8 |
|
4018
Mustang Bio
MBIO
$4.5M
| $18K | ﹤0.01% |
25,704
| – | – |
|
|
HCWC
4019
Healthy Choice Wellness
HCWC
$7.22M
| $17.8K | ﹤0.01% |
91,961
| – | – |
|
4020
ClearOne Inc
CLRO
$14M
| $17.5K | ﹤0.01% |
5,258
| – | – |
|
|
CHGA
4021
Change Agents Corp
CHGA
$3.83M
| $16.7K | ﹤0.01% |
57,325
| – | – |
|
|
VIVS
4022
VivoSim Labs
VIVS
$1.11M
| $16.4K | ﹤0.01% |
15,371
| – | – |
|
4023
Presidio Property Trust
SQFT
$2.12M
| $16.3K | ﹤0.01% |
6,645
| – | – |
|
4024
Cenntro
CENN
$8.63M
| $15.9K | ﹤0.01% |
4,453
+1
| +0% | +$4 |
|
|
YHC
4025
LQR House Inc
YHC
$2.2M
| $15.8K | ﹤0.01% |
2,001
| – | – |
|
Similar funds
Vanguard Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Capital Management held 4,163 positions worth $4.68T, up 16% from $4.04T the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 4.1%. Vanguard Capital Management opened 101 new positions and exited 71, leaving the 4,163-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- Vanguard Capital Management's largest Q2 2026 buy was Honeywell Aerospace: 20,693,166 shares worth $4.57B.
- Vanguard Capital Management added most to Marvell Technology in Q2 2026, an estimated $3.77B increase.
- Vanguard Capital Management's biggest Q2 2026 reduction was Honeywell, cutting an estimated $4.59B.
- Vanguard Capital Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.69B.
- Vanguard Capital Management's ten largest holdings make up 33% of its $4.68T portfolio in Q2 2026.
- Vanguard Capital Management opened 101 new positions and closed 71 in Q2 2026.
- Vanguard Capital Management's portfolio value rose 16% quarter-over-quarter to $4.68T.
Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.